Mary Gospodarowicz is a radiation oncologist at the Princess Margaret Cancer Centre and University Professor at the University of Toronto. Her research focused on clinical trials evaluating radiation therapy, image-guided precision radiotherapy, and cancer survivorship. Her current interests include global cancer control, global access to radiotherapy, cancer staging and prognosis. Dr. Gospodarowicz is a Past-President of the Union for International Cancer Control (UICC) and continues to co-chair the UICC TNM Prognostic Factors Project. She initiated the Lancet Oncology Commission on Global Access to Radiotherapy and participated in the HGEI Global Task Force on Cancer Care and Control and the HGEI-Lancet Commission on Global Access to Pain Control & Palliative Care. She is currently a member of the Board of Directors of the City Cancer Challenge Foundation.
Disclosures:
- Employment: none
- Compensation: none
- Ownership: none
- Leadership: none